Weight-loss drug approved to treat sleep apnea in Canada

CBC·Jun 24

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A weight-loss drug has been approved in Canada to treat sleep apnea. The approval is specifically for adults with obesity, and it is reportedly the first medication of its kind for this condition in Canada. The development may have financial implications for plan sponsors, and its impact on coverage is being considered.

Full coverage

Approval of weight loss drug for sleep apnea could create financial risk for plan sponsors: expert

Benefits Canada.com·1d ago

New treatment option arrives for Canadians with sleep apnea and obesity

CTV News·Jun 22

Health Canada Approves Zepbound for OSA in Adults With Obesity

Sleep Review·Jun 24

Health Canada approves ZEPBOUND® as the first-ever obstructive sleep apnea medication in Canada for adults living with obesity

Yahoo Finance·Jun 16

Health Canada has approved the first sleep apnea drug for adults with obesity

Benefits and Pensions Monitor·Jun 24

Health Matters: Health Canada approves Zepbound to treat obstructive sleep apnea

Global News·Jun 24

Sleep apnea drug approved in Canada — plan sponsors must weigh coverage

Benefits and Pensions Monitor·Jun 16

Sleep apnea pill shows striking success in large clinical trial

Science | AAAS·May 22

View original report at CBC ↗

Fetching the latest headlines…